[HTML][HTML] Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease

JE Horowitz, JA Kosmicki, A Damask, D Sharma… - Nature …, 2022 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters human host cells
via angiotensin-converting enzyme 2 (ACE2) and causes coronavirus disease 2019 (COVID-…

Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease susceptibility

…, GA Heap, M Hiltunen, M Hoeppner, JE Horowitz… - Nature …, 2022 - nature.com
Genome-wide association studies (GWASs) have identified hundreds of loci associated with
Crohn’s disease (CD). However, as with all complex diseases, robust identification of the …

[HTML][HTML] Whole-genome sequencing reveals host factors underlying critical COVID-19

…, D Bentley, C Kingsley, JA Kosmicki, JE Horowitz… - Nature, 2022 - nature.com
Critical COVID-19 is caused by immune-mediated inflammatory lung injury. Host genetic
variation influences the development of illness requiring critical care 1 or hospitalization 2 , 3 – …

Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial

…, MM Boomsma, H Staudinger, JE Horowitz… - The Lancet …, 2021 - thelancet.com
Background Genetic data implicate IL-33 in asthma susceptibility. Itepekimab, a monoclonal
antibody targeting IL-33, demonstrated clinical activity in asthma, with potential in chronic …

[PDF][PDF] Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals

JA Kosmicki, JE Horowitz, N Banerjee, R Lanche… - The American Journal of …, 2021 - cell.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus disease
2019 (COVID-19), a respiratory illness that can result in hospitalization or death. We used …

Efficacy and safety of sarilumab in hospitalized patients with coronavirus disease 2019: a randomized clinical trial

…, SM Brown, JA Kosmicki, JE Horowitz… - Clinical Infectious …, 2022 - academic.oup.com
Background Open-label platform trials and a prospective meta-analysis suggest efficacy of
anti–interleukin (IL)-6R therapies in hospitalized patients with coronavirus disease 2019 (…

[HTML][HTML] Mutation spectrum of NOD2 reveals recessive inheritance as a main driver of Early Onset Crohn's Disease

JE Horowitz, N Warner, J Staples, E Crowley… - Scientific reports, 2021 - nature.com
Inflammatory bowel disease (IBD), clinically defined as Crohn’s disease (CD), ulcerative
colitis (UC), or IBD-unclassified, results in chronic inflammation of the gastrointestinal tract in …

Lineage-specific compaction of Tcrb requires a chromatin barrier to protect the function of a long-range tethering element

…, OI Koues, EAW Chan, KE Kyle, JE Horowitz… - Journal of Experimental …, 2015 - rupress.org
Gene regulation relies on dynamic changes in three-dimensional chromatin conformation,
which are shaped by composite regulatory and architectural elements. However, mechanisms …

A randomized placebo-controlled trial of sarilumab in hospitalized patients with Covid-19

…, JA Aberg, SM Brown, JA Kosmicki, JE Horowitz… - MedRxiv, 2021 - medrxiv.org
BACKGROUND Sarilumab (anti-interleukin-6 receptor-α monoclonal antibody) may attenuate
the inflammatory response in Covid-19. METHODS We performed an adaptive, phase 2/3, …

Sequencing of over 100,000 individuals identifies multiple genes and rare variants associated with Crohns disease susceptibility

…, GA Heap, M Hiltunen, M Hoeppner, JE Horowitz… - medRxiv, 2021 - medrxiv.org
Genome-wide association studies (GWAS) have identified hundreds of loci associated with
Crohns disease (CD), however, as with all complex diseases, deriving pathogenic …